Literature DB >> 7985035

Gastrointestinal manifestations of systemic sclerosis.

M Abu-Shakra1, F Guillemin, P Lee.   

Abstract

Gastrointestinal (GI) manifestations of systemic sclerosis (SSc) were found in 82% of 262 patients followed up prospectively. Esophageal dysmotility, lower esophageal sphincter laxity, bacterial overgrowth, and wide mouth diverticuli were the most common findings. The disease is usually diffuse with multiple levels of involvement. Gastrointestinal involvement was not significantly correlated with gender, age at SSc diagnosis or disease type (limited or diffuse scleroderma). Upper GI symptoms develop early in the course of SSc and may not correlate with objective findings. Various investigations, treatment regimens, and less frequent disease manifestations are reviewed and discussed.

Entities:  

Mesh:

Year:  1994        PMID: 7985035     DOI: 10.1016/0049-0172(94)90097-3

Source DB:  PubMed          Journal:  Semin Arthritis Rheum        ISSN: 0049-0172            Impact factor:   5.532


  28 in total

1.  Investigation of anal function in patients with systemic sclerosis.

Authors:  A L Herrick; J D Barlow; A Bowden; N Williams; A R Hobson; M Irving; M I Jayson
Journal:  Ann Rheum Dis       Date:  1996-06       Impact factor: 19.103

2.  Gastric slow waves, gastrointestinal symptoms and peptides in systemic sclerosis patients.

Authors:  T A McNearney; H S Sallam; S E Hunnicutt; D Doshi; D E Wollaston; M D Mayes; J D Z Chen
Journal:  Neurogastroenterol Motil       Date:  2009-06-30       Impact factor: 3.598

3.  Management of gastrointestinal involvement in scleroderma.

Authors:  Vivek Nagaraja; Zsuzsanna H McMahan; Terri Getzug; Dinesh Khanna
Journal:  Curr Treatm Opt Rheumatol       Date:  2015-03-01

4.  The association between systemic sclerosis disease manifestations and esophageal high-resolution manometry parameters.

Authors:  J N Kimmel; D A Carlson; M Hinchcliff; M A Carns; K A Aren; J Lee; J E Pandolfino
Journal:  Neurogastroenterol Motil       Date:  2016-02-27       Impact factor: 3.598

Review 5.  Dysphagia: current reality and scope of the problem.

Authors:  Pere Clavé; Reza Shaker
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2015-04-07       Impact factor: 46.802

Review 6.  Role and safety of fundoplication in esophageal disease and dysmotility syndromes.

Authors:  Charles T Bakhos; Roman V Petrov; Henry P Parkman; Zubair Malik; Abbas E Abbas
Journal:  J Thorac Dis       Date:  2019-08       Impact factor: 2.895

7.  Validation of Serbian version of UCLA Scleroderma Clinical Trial Consortium Gastrointestinal Tract Instrument in 104 patients with systemic sclerosis.

Authors:  Ana Zekovic; Nemanja Damjanov
Journal:  Rheumatol Int       Date:  2017-03-07       Impact factor: 2.631

8.  Diffuse systemic sclerosis and autoimmune hepatitis: a unique association.

Authors:  Carlos Ewerton Maia Rodrigues; Cláudia Lobato Borges; Jozélio Freire de Carvalho
Journal:  Clin Rheumatol       Date:  2010-02-07       Impact factor: 2.980

9.  Clinical Assessment of Gastrointestinal Involvement in Patients with Systemic Sclerosis.

Authors:  Timothy Kaniecki; Tsion Abdi; Zsuzsanna H McMahan
Journal:  Med Res Arch       Date:  2020-10-29

10.  Loss of Peristaltic Reserve, Determined by Multiple Rapid Swallows, Is the Most Frequent Esophageal Motility Abnormality in Patients With Systemic Sclerosis.

Authors:  Dustin A Carlson; Michael D Crowell; Jessica N Kimmel; Amit Patel; C Prakash Gyawali; Monique Hinchcliff; W Leroy Griffing; John E Pandolfino; Marcelo F Vela
Journal:  Clin Gastroenterol Hepatol       Date:  2016-04-05       Impact factor: 11.382

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.